doxorubicin in combination with palifosfamide-tris
IPM3001
Phase 3 small_molecule completed
Quick answer
doxorubicin in combination with palifosfamide-tris for Soft Tissue Sarcoma is a Phase 3 program (small_molecule) at Alaunos Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alaunos Therapeutics
- Indication
- Soft Tissue Sarcoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed